ASHLAND, Mass., July 23 MatTek Corp., today announced the availability of a video version of its 2008 ECVAM-validated EpiDerm(TM) SIT non-animal alternative test method for determining the human skin irritation potential of chemicals, including cosmetic and pharmaceutical ingredients.
This 20 minute video article was published in the Journal of Visualized Experiments (JoVE). Titled, "An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model", this peer-reviewed, PubMed-indexed video article is now available for online viewing on both the MatTek (WWW.MATTEK.COM) and JoVE Web sites.
In the video, Dr. Helena Kandarova, a Senior Scientist at MatTek, demonstrates the detailed steps in the EpiDerm Skin Irritation Test (SIT) protocol. Dr. Kandarova, based in the European Union (EU), played a central role in developing this test method, which in 2007 was subjected to a blind validation trial among four EU and US-based laboratories. Dr. Kandarova noted, "The video format permits MatTek to demonstrate the procedure in great detail allowing for better understanding and faster implementation by lab personnel who are new to this type of non-animal test method."
John Sheasgreen, MatTek's President, explained the need for the video, "We knew the recent validation of the EpiDerm SIT method combined with a full ban on the use of animals for this test in the EU would create unprecedented demand from organizations worldwide for information on how to perform this test. To meet this need, we felt video was the best choice to distribute the information quickly, accurately and to as many scientists as possible."
"MatTek published in JoVE because we were impressed with JoVE's ability to produce a professional video that is peer-reviewed and indexed in PubMed," noted Dave Ingalls, Sales & Marketing Manager. "Peer-review and PubMed indexing will assure scientists that they are viewing an accurate representation of this ECVAM-validated method."
About MatTek - MatTek Corp. is the world's largest independent producer of in vitro human epithelial tissue equivalents. With over 15 years of publicly available QC data and over 400 technical references supporting our claim of "Unsurpassed Long-Term Tissue Reproducibility", MatTek human tissue equivalents are used in product development, claims substantiation (over 200 patent references cite the use of MatTek tissues), safety assessment, and drug discovery/development in many industries including Cosmetics, Personal Care, Household Products, Chemicals, Pharmaceuticals and Biotech.
SOURCE MatTek Corp.